Physician Assistant, Medical · Denver, CO
NPI
1518211051
Since 2012
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
950 East Harvard Ave Ste 570
Denver, CO, 80210
Phone (303) 715-9024
Groups this clinician bills Medicare through
Medicare paid, 2022
$55K
6,664 services
Medicare patients, 2022
140
Average age 71
Drug cost, 2024
$1.3M
2,103 prescriptions
Company payments, 2025
$89K
From 44 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Jordan M Mast was code J0585 (injection, onabotulinumtoxina, 1 unit), 4,600 times for 14 patients. In total Jordan M Mast billed 6,664 services in 18 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 4,600 | 14 | $4.92 | $23K |
| 99215 Office E&M - Established | Office | 139 | 84 | $103.01 | $14K |
| 99213 Office E&M - Established | Office | 29 | 18 | $56.67 | $1,643 |
| 64615 Musculoskeletal | Office | 19 | 13 | $95.41 | $1,813 |
| 99205 Office E&M - New | Office | 18 | 18 | $145.89 | $2,626 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $133.52 | $2,403 |
Medicare prescription drug claims, 2024
In 2024, the drug Jordan M Mast prescribed most often to Medicare patients was Gabapentin, with 217 prescriptions and refills. In total Jordan M Mast wrote 2,103 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 217 | 357 | 48 | $3,658 |
| Emgality Pen Galcanezumab-Gnlm | 126 | 140 | 17 | $97K |
| Lamotrigine Generic | 99 | 133 | 15 | $886 |
| Topiramate Generic | 86 | 152 | 13 | $1,303 |
| Donepezil Hcl Generic | 81 | 164 | 19 | $825 |
| Levetiracetam Generic | 68 | 133 | 15 | $2,605 |
| Qulipta Atogepant | 66 | 66 | Under 11 | $76K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 64 | 132 | 19 | $1,400 |
| Nurtec Odt Rimegepant Sulfate | 49 | 49 | 15 | $65K |
| Pregabalin Generic | 49 | 71 | 12 | $1,249 |
| Clopidogrel Clopidogrel Bisulfate | 46 | 100 | 14 | $457 |
| Nortriptyline Hcl Generic | 45 | 66 | Under 11 | $1,040 |
| Aimovig Autoinjector Erenumab-Aooe | 44 | 50 | Under 11 | $37K |
| Levetiracetam Er Levetiracetam | 42 | 79 | Under 11 | $2,217 |
| Ubrelvy Ubrogepant | 41 | 43 | 13 | $60K |
Brand drugs: 492 claims; generic drugs: 1,598 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jordan M Mast $89K ($88K in general payments such as food, travel and fees and $780 for research) from 44 companies. The largest payer was Abbvie Inc. with $32K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 120 | $32K |
| Lilly USA, LLC LLY | 52 | $23K |
| Pfizer Inc. PFE | 44 | $9,665 |
| Eisai Inc. 4523.T | 24 | $9,361 |
| Axsome Therapeutics, Inc. AXSM | 25 | $8,118 |
| Lundbeck LLC | 16 | $841 |
| TG Therapeutics, Inc. TGTX | 12 | $415 |
| Alexion Pharmaceuticals, Inc. AZN | 12 | $369 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $364 |
| Amgen Inc. AMGN | 5 | $346 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.